[
  {
    "ts": null,
    "headline": "IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features",
    "summary": "IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features",
    "url": "https://finnhub.io/api/news?id=fd445e2724625e6a109ff734f0648892f87df7df2e8e983c77c57a0bb579559e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772209080,
      "headline": "IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features",
      "id": 139256613,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fd445e2724625e6a109ff734f0648892f87df7df2e8e983c77c57a0bb579559e"
    }
  },
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?",
    "summary": "Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=2ee209e09e3f1daede997c727fa331c043d71ae3372270a0195213931e0f139b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772208976,
      "headline": "Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?",
      "id": 139255735,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=2ee209e09e3f1daede997c727fa331c043d71ae3372270a0195213931e0f139b"
    }
  }
]